Previous Article | Next Article 
Journal of Virology, December 2000, p. 11717-11723, Vol. 74, No. 24
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Mutational Analysis of Conserved Domains within the
Cytoplasmic Tail of gp41 from Human Immunodeficiency Virus Type 1:
Effects on Glycoprotein Incorporation and Infectivity
Sabine C.
Piller,
John W.
Dubay,
Cynthia A.
Derdeyn, and
Eric
Hunter*
Department of Microbiology, University of
Alabama at Birmingham, Birmingham, Alabama 35294
Received 25 February 2000/Accepted 25 September 2000
The transmembrane (TM) glycoprotein gp41 of human immunodeficiency
virus type 1 possesses an unusually long (~150 amino acids) and
highly conserved cytoplasmic region. Previous studies in which this
cytoplasmic tail had been deleted partially or entirely have suggested
that it is important for virus infectivity and incorporation of the
gp120-gp41 glycoprotein complex into virions. To determine which
regions of the conserved C-terminal domains are important for
glycoprotein incorporation and infectivity, several small deletions and
amino acid substitutions which modify highly conserved motifs were
constructed in the infectious proviral background of NL4.3. The effects
of these mutations on infectivity and glycoprotein incorporation into
virions produced from transfected 293-T cells and infected H9 and
CEM×174 cells were determined. With the exception of a mutation
deleting amino acids QGL, all of the constructs resulted in decreased
infectivity of the progeny virus both in a single-round infectivity
assay and in a multiple-infection assay in H9 and CEM×174 cells. For
most mutations, the decreased infectivity was correlated with a
decreased incorporation of glycoprotein into virions. Substitution
of the arginines (residues 839 and 846) with glutamates also reduced
infectivity, but without a noticeable decrease in the amount of
glycoprotein incorporated into virus produced from infected T cells.
These results demonstrate that minor alterations in the conserved
C-terminal region of the gp41 cytoplasmic tail can result in reductions
in infectivity that correlate for most but not all constructs with a
decrease in glycoprotein incorporation. Observed cell-dependent
differences suggest the involvement of cellular factors in regulating
glycoprotein incorporation and infectivity.
*
Corresponding author. Mailing address: Center for AIDS
Research, University of Alabama at Birmingham, Bevill Biomedical
Research Building, Rm. 256D, 845 19th St. South, Birmingham, AL
35294-2170. Phone: (205) 934-4321. Fax: (205) 934-1640. E-mail:
ehunter{at}uab.edu.
Journal of Virology, December 2000, p. 11717-11723, Vol. 74, No. 24
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Beaumont, E., Vendrame, D., Verrier, B., Roch, E., Biron, F., Barin, F., Mammano, F., Brand, D.
(2009). Matrix and Envelope Coevolution Revealed in a Patient Monitored since Primary Infection with Human Immunodeficiency Virus Type 1. J. Virol.
83: 9875-9889
[Abstract]
[Full Text]
-
Montero, M., van Houten, N. E., Wang, X., Scott, J. K.
(2008). The Membrane-Proximal External Region of the Human Immunodeficiency Virus Type 1 Envelope: Dominant Site of Antibody Neutralization and Target for Vaccine Design. Microbiol. Mol. Biol. Rev.
72: 54-84
[Abstract]
[Full Text]
-
Jiang, J., Aiken, C.
(2007). Maturation-Dependent Human Immunodeficiency Virus Type 1 Particle Fusion Requires a Carboxyl-Terminal Region of the gp41 Cytoplasmic Tail. J. Virol.
81: 9999-10008
[Abstract]
[Full Text]
-
Tahara, M., Takeda, M., Yanagi, Y.
(2007). Altered Interaction of the Matrix Protein with the Cytoplasmic Tail of Hemagglutinin Modulates Measles Virus Growth by Affecting Virus Assembly and Cell-Cell Fusion. J. Virol.
81: 6827-6836
[Abstract]
[Full Text]
-
Lambele, M., Labrosse, B., Roch, E., Moreau, A., Verrier, B., Barin, F., Roingeard, P., Mammano, F., Brand, D.
(2007). Impact of Natural Polymorphism within the gp41 Cytoplasmic Tail of Human Immunodeficiency Virus Type 1 on the Intracellular Distribution of Envelope Glycoproteins and Viral Assembly. J. Virol.
81: 125-140
[Abstract]
[Full Text]
-
Lopez-Verges, S., Camus, G., Blot, G., Beauvoir, R., Benarous, R., Berlioz-Torrent, C.
(2006). Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions. Proc. Natl. Acad. Sci. USA
103: 14947-14952
[Abstract]
[Full Text]
-
Li, M., Li, Z.-N., Yao, Q., Yang, C., Steinhauer, D. A., Compans, R. W.
(2006). Murine Leukemia Virus R Peptide Inhibits Influenza Virus Hemagglutinin-Induced Membrane Fusion.. J. Virol.
80: 6106-6114
[Abstract]
[Full Text]
-
Davis, M. R., Jiang, J., Zhou, J., Freed, E. O., Aiken, C.
(2006). A Mutation in the Human Immunodeficiency Virus Type 1 Gag Protein Destabilizes the Interaction of the Envelope Protein Subunits gp120 and gp41. J. Virol.
80: 2405-2417
[Abstract]
[Full Text]
-
Yuste, E., Johnson, W., Pavlakis, G. N., Desrosiers, R. C.
(2005). Virion Envelope Content, Infectivity, and Neutralization Sensitivity of Simian Immunodeficiency Virus. J. Virol.
79: 12455-12463
[Abstract]
[Full Text]
-
Song, C., Micoli, K., Hunter, E.
(2005). Activity of the Mason-Pfizer Monkey Virus Fusion Protein Is Modulated by Single Amino Acids in the Cytoplasmic Tail. J. Virol.
79: 11569-11579
[Abstract]
[Full Text]
-
Miyauchi, K., Komano, J., Yokomaku, Y., Sugiura, W., Yamamoto, N., Matsuda, Z.
(2005). Role of the Specific Amino Acid Sequence of the Membrane-Spanning Domain of Human Immunodeficiency Virus Type 1 in Membrane Fusion. J. Virol.
79: 4720-4729
[Abstract]
[Full Text]
-
Cheung, L., McLain, L., Hollier, M. J., Reading, S. A., Dimmock, N. J.
(2005). Part of the C-terminal tail of the envelope gp41 transmembrane glycoprotein of human immunodeficiency virus type 1 is exposed on the surface of infected cells and is involved in virus-mediated cell fusion. J. Gen. Virol.
86: 131-138
[Abstract]
[Full Text]
-
Yuste, E., Reeves, J. D., Doms, R. W., Desrosiers, R. C.
(2004). Modulation of Env Content in Virions of Simian Immunodeficiency Virus: Correlation with Cell Surface Expression and Virion Infectivity. J. Virol.
78: 6775-6785
[Abstract]
[Full Text]
-
Song, C., Dubay, S. R., Hunter, E.
(2003). A Tyrosine Motif in the Cytoplasmic Domain of Mason-Pfizer Monkey Virus Is Essential for the Incorporation of Glycoprotein into Virions. J. Virol.
77: 5192-5200
[Abstract]
[Full Text]
-
Kalia, V., Sarkar, S., Gupta, P., Montelaro, R. C.
(2003). Rational Site-Directed Mutations of the LLP-1 and LLP-2 Lentivirus Lytic Peptide Domains in the Intracytoplasmic Tail of Human Immunodeficiency Virus Type 1 gp41 Indicate Common Functions in Cell-Cell Fusion but Distinct Roles in Virion Envelope Incorporation. J. Virol.
77: 3634-3646
[Abstract]
[Full Text]
-
Cleveland, S. M., McLain, L., Cheung, L., Jones, T. D., Hollier, M., Dimmock, N. J.
(2003). A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion. J. Gen. Virol.
84: 591-602
[Abstract]
[Full Text]
-
Lee, S.-F., Ko, C.-Y., Wang, C.-T., Chen, S. S.-L.
(2002). Effect of Point Mutations in the N Terminus of the Lentivirus Lytic Peptide-1 Sequence of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41 on Env Stability. J. Biol. Chem.
277: 15363-15375
[Abstract]
[Full Text]
-
Plemper, R. K., Hammond, A. L., Gerlier, D., Fielding, A. K., Cattaneo, R.
(2002). Strength of Envelope Protein Interaction Modulates Cytopathicity of Measles Virus. J. Virol.
76: 5051-5061
[Abstract]
[Full Text]
-
Edwards, T. G., Wyss, S., Reeves, J. D., Zolla-Pazner, S., Hoxie, J. A., Doms, R. W., Baribaud, F.
(2002). Truncation of the Cytoplasmic Domain Induces Exposure of Conserved Regions in the Ectodomain of Human Immunodeficiency Virus Type 1 Envelope Protein. J. Virol.
76: 2683-2691
[Abstract]
[Full Text]
-
Evans, D. T., Tillman, K. C., Desrosiers, R. C.
(2002). Envelope Glycoprotein Cytoplasmic Domains from Diverse Lentiviruses Interact with the Prenylated Rab Acceptor. J. Virol.
76: 327-337
[Abstract]
[Full Text]